Teikoku Backs Up Bid To DQ 12 Firms In Lidoderm MDL
Japanese drugmaker Teikoku doubled down Thursday on its bid to disqualify at least 12 law firms representing retailers in pay-for-delay multidistrict litigation over the drug Lidoderm for using a privileged document...To view the full article, register now.
Already a subscriber? Click here to view full article